Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 0.6700
-0.0250 (-3.60%)
At close: Apr 16, 2025
Genetic Analysis AS Revenue
In the year 2024, Genetic Analysis AS had annual revenue of 20.68M NOK, down -10.70%. Genetic Analysis AS had revenue of 7.34M in the quarter ending December 31, 2024, with 15.26% growth.
Revenue
20.68M NOK
Revenue Growth
-10.70%
P/S Ratio
1.52
Revenue / Employee
984.95K NOK
Employees
21
Market Cap
30.56M SEK
Revenue Chart
* This company reports financials in NOK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 34.76B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |